Robert S. Brown, President, Kidney Care at NxStage Medical, Inc. (NXTM), sold 140,100 shares at $14.00 ($2.0M) on 2013-10-21, disclosed to the SEC on 2013-10-22.
Scheduled sale ($2.0M) by President, Kidney Care under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.00 | 64,791 | $907K | 46.2% |
| 2 | $14.00 | 75,309 | $1.1M | 53.8% |
| Total | $14.00 avg | 140,100 | $2.0M | 100% |
| Filing → |
| NXTM | SELL | 2017-03-06 | $358K | — | Filing → |
| NXTM | SELL | 2017-02-15 | $138K | — | Filing → |
| NXTM | SELL | 2017-02-08 | $169K | — | Filing → |